CClinicalTrials.gg
Not yet recruitingNCT07843628Updated Sep 28, 2026

Predictors of In-Hospital Mortality in Severe Abdominal Trauma

An observational study in Abdominal Injuries, Wounds and Injuries and Wounds, Nonpenetrating, sponsored by Minia University. Not yet recruiting at 1 site in Egypt. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by Minia University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
430
Ages
16 Years and older
Sex
All
01

Study summary

Severe abdominal trauma is a leading cause of early death from bleeding and of later death from sepsis and organ failure. Clinicians use scoring systems to estimate the risk of dying, but most of these scores were developed and calibrated in high-income trauma systems and may perform differently in high-volume referral hospitals elsewhere, where patients frequently arrive after a prehospital delay and already in established shock.

This study will prospectively follow consecutive patients aged 16 years and older admitted to a single tertiary trauma centre with severe abdominal injury over a 12-month period. Severe abdominal trauma is defined as an Abbreviated Injury Scale score of 3 or more for the abdominal region, and/or an abdominal injury requiring emergency laparotomy, laparoscopy or angioembolisation, and/or admission to intensive care for management of an abdominal injury. A total of 430 evaluable patients is anticipated.

Information generated as part of routine trauma care will be recorded prospectively from arrival until hospital discharge: age, sex and comorbidity; injury mechanism, time from injury to arrival and mode of arrival; arrival physiology (systolic blood pressure, heart rate, shock index, Glasgow Coma Scale, respiratory rate, oxygen saturation, temperature); admission biochemistry (arterial lactate, base deficit, pH, haemoglobin, platelet count, INR); imaging and operative findings with American Association for the Surgery of Trauma organ injury grades; transfusion and operative management; and in-hospital complications.

The primary outcome is in-hospital all-cause mortality. Survivors and non-survivors will be compared, and a multivariable logistic regression model will be built to identify admission and early in-hospital variables that independently predict death. Model discrimination and calibration will be assessed and internally validated by bootstrap resampling, and performance will be compared with that of the Injury Severity Score, Revised Trauma Score, TRISS and the MGAP score. If the model is robust, a simplified integer bedside risk score will be derived and internally validated.

The study is purely observational: it mandates no additional investigations, interventions or visits, and all clinical decisions remain with the attending trauma team according to institutional ATLS-based protocols. The findings are intended to support locally valid triage, transfusion and damage-control decision-making and to enable fair outcome benchmarking between comparable centres.

Read the detailed description

Background and rationale Trauma is among the leading causes of death and disability worldwide and the foremost cause of mortality in the first four decades of life. The abdomen is involved in a substantial proportion of severe injuries, and abdominal trauma contributes disproportionately to early haemorrhagic death and to late mortality from sepsis and multi-organ dysfunction. Outcomes are determined by the interplay of injury anatomy, physiological reserve, the timeliness and adequacy of resuscitation, and the surgical and critical-care response. Existing instruments that quantify this risk - the anatomical Injury Severity Score (ISS), the physiological Revised Trauma Score (RTS), the combined TRISS, and simpler bedside tools such as MGAP - were predominantly derived and calibrated in high-income trauma systems, and their transferability to high-volume centres in resource-constrained settings is uncertain. Reliance on imported risk estimates may misclassify risk, distort benchmarking, and provide limited guidance for triage, activation of massive transfusion, and the choice between definitive repair and damage-control surgery.

Knowledge gap Despite an extensive trauma-scoring literature, there are few prospective single-centre data from high-volume tertiary trauma units in low- and middle-income settings that (i) focus specifically on severe abdominal trauma rather than polytrauma in aggregate, (ii) capture early dynamic physiological and biochemical markers (lactate, base deficit, coagulopathy indices) alongside anatomical grading, and (iii) directly compare locally derived predictors against established scores using contemporary prediction-model methodology with internal validation.

Objectives Primary objective: to identify independent predictors of in-hospital all-cause mortality among patients presenting with severe abdominal trauma at a tertiary trauma centre. Secondary objectives: to describe the demographic, mechanistic, physiological, biochemical and anatomical-injury profile of the cohort and compare survivors with non-survivors; to quantify the discrimination (AUROC) and calibration of a multivariable model built from routinely available admission and early in-hospital variables; to compare the derived model with ISS, RTS, TRISS and MGAP; to describe secondary outcomes (24-hour mortality, intensive-care mortality, massive transfusion, damage-control surgery, major complications and length of stay) and their association with candidate predictors; and, where statistically supported, to derive a simplified, internally validated bedside risk score.

Hypothesis A defined set of admission and early in-hospital variables - in particular age, depth of physiological derangement (systolic blood pressure, shock index, Glasgow Coma Scale), metabolic markers of shock (lactate, base deficit), coagulopathy, transfusion intensity and anatomical injury burden - are independently associated with in-hospital mortality, and a model combining these variables achieves discrimination at least comparable to established trauma scores in this population.

Design and setting Single-centre, prospective observational cohort study conducted in the Emergency Trauma Unit and Department of Surgery of Minia University Hospitals, Minia, Egypt - a tertiary referral centre with 24-hour emergency surgical, interventional-radiology, blood-bank and intensive-care services, receiving both primary presentations and referrals from secondary facilities. Consecutive eligible patients are enrolled at admission and followed until hospital discharge or in-hospital death. No study-mandated intervention is applied. Reporting follows the STROBE statement, and the prediction-model component additionally follows TRIPOD.

Variables and data sources Candidate predictors were selected a priori on the basis of biological plausibility, established association with trauma mortality, and routine availability at admission or during the first hours of care. They span six domains: demographic (age, sex, relevant comorbidity); mechanism and prehospital (blunt versus penetrating and sub-type, time from injury to arrival, direct versus referred arrival); arrival physiology (systolic blood pressure, heart rate, shock index, Glasgow Coma Scale, respiratory rate, oxygen saturation, temperature); admission biochemistry and haematology (arterial lactate, base deficit, pH, haemoglobin, platelet count, INR); anatomical injury (AIS-abdomen, ISS, number of injured intra-abdominal organs, organ-specific AAST grade, major vascular injury, associated extra-abdominal injury, eFAST and estimated haemoperitoneum); and resuscitation and operative management (time from arrival to operation, massive transfusion, 24-hour packed-red-cell units, damage-control surgery, vasopressor requirement). Data are collected prospectively on a standardised case-report form and cross-checked against the emergency record, operative notes, laboratory and imaging systems, blood-bank record and intensive-care chart, with daily verification by a dedicated coordinator. AAST grading is assigned by the operating surgeon and verified against imaging by a second reviewer, and ISS, RTS, TRISS and MGAP are computed by an investigator blinded to eventual outcome wherever feasible.

Sample size The sample size is driven by the requirements of multivariable prediction modelling rather than a single hypothesis test. Institutional volume is approximately 250 patients with severe abdominal trauma annually, so 12-month enrolment is expected to yield close to 430 evaluable patients. Anticipating in-hospital mortality of approximately 20%, 430 patients generate an expected 86 deaths; applying at least ten events per variable supports a model containing up to eight independent predictors, and the final model will be constrained to eight or fewer variables. Using contemporary sample-size criteria for clinical prediction models (anticipated C-statistic approximately 0.80, outcome prevalence 0.20, up to 12 candidate parameters considered), the minimum required sample is below 400; the planned 430 provides a margin of roughly 10% for incomplete data.

Statistical analysis Continuous variables will be summarised as mean with standard deviation or median with interquartile range according to distribution (Shapiro-Wilk), and categorical variables as frequencies and percentages, overall and stratified by the primary outcome. Survivors and non-survivors will be compared using the independent-samples t-test or Mann-Whitney U test and the chi-square or Fisher exact test. Variables associated with mortality at p \< 0.10, together with predictors judged clinically essential a priori, will enter a multivariable binary logistic regression model with in-hospital mortality as the dependent variable. Linearity of the logit will be checked and collinearity screened using variance-inflation factors. Adjusted odds ratios with 95% confidence intervals will be reported, with two-sided significance at p \< 0.05.

Model performance, validation and score derivation Discrimination will be quantified by the area under the receiver-operating-characteristic curve and calibration by the Hosmer-Lemeshow test and a calibration plot. Internal validation will use bootstrap resampling with 1,000 replicates to derive optimism-corrected estimates. The derived model will be compared with ISS, RTS, TRISS and MGAP using the DeLong test for correlated AUROCs. If the model is robust and well calibrated, a simplified integer risk score will be derived by assigning points proportional to the regression coefficients, internally validated by the same bootstrap procedure, and reported with risk strata and corresponding predicted mortality.

Missing data, sensitivity and subgroup analyses The pattern and extent of missing data will be reported. Where a variable has less than 20% missing values assumed missing at random, multiple imputation by chained equations with pooling by Rubin's rules will be used, and a complete-case analysis reported as a sensitivity analysis. Further sensitivity analyses will examine 24-hour and intensive-care mortality as alternative endpoints and will repeat the primary analysis after excluding early deaths occurring within one hour. Pre-specified subgroup analyses will examine injury mechanism (blunt versus penetrating), age group (60 years and over versus under 60) and the presence of major vascular injury, assessed by interaction terms and interpreted with caution given reduced power. Analyses will be performed using SPSS version 27 or later and R version 4.3 or later (pROC, rms and mice packages).

Oversight and quality assurance As a non-interventional observational study that imposes no change to clinical care, a formal data and safety monitoring board is not required. A study oversight group comprising the principal investigator, a senior trauma surgeon and the study statistician will meet at least every six months to review recruitment, completeness and quality, and to approve protocol amendments before submission to the ethics committee. All investigators and data collectors complete structured training before enrolment begins. At least 10% of completed case-report forms will be independently source-verified by a team member not involved in the original entry, and inter-rater agreement for AIS and AAST grading will be quantified by Cohen's or weighted kappa on a random subset. Protocol deviations will be recorded in a deviation log.

Anticipated limitations As a single-centre study, findings may have limited generalisability to centres with different case mix, prehospital systems or resources, and external validation will be required before clinical adoption of any derived score. A prospective observational design cannot establish causation; identified predictors are markers of risk rather than necessarily modifiable causes of death. Some early deaths and prehospital variables may be incompletely captured. Internal validation by bootstrapping reduces but does not eliminate optimism. Referral patterns may introduce selection effects, as the most severely injured patients may die before reaching the centre.

02

Conditions studied

  • Abdominal Injuries
  • Wounds and Injuries
  • Wounds, Nonpenetrating
  • Wounds, Penetrating
  • Multiple Trauma
  • Shock, Hemorrhagic
  • Hospital Mortality

Keywords

  • Abdominal trauma
  • Blunt abdominal trauma
  • Penetrating abdominal trauma
  • In-hospital mortality
  • Prediction model
  • Risk stratification
  • Shock index
  • Arterial lactate
  • Base deficit
  • Trauma-induced coagulopathy
  • Massive transfusion
  • Damage-control surgery
  • Injury Severity Score
  • Revised Trauma Score
  • TRISS
  • MGAP score
  • AAST organ injury scale
03

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

Consecutive patients aged 16 years and older presenting to the Emergency Trauma Unit of Minia University Hospitals, Minia, Egypt, within 24 hours of blunt or penetrating abdominal injury and meeting the protocol definition of severe abdominal trauma. The centre is a tertiary referral hospital serving a large catchment population and receives both primary presentations and referrals from secondary facilities.

Inclusion criteria

  • Age 16 years or older.
  • Abdominal trauma, blunt or penetrating, meeting at least one criterion for severity: Abbreviated Injury Scale (AIS) for the abdominal region of 3 or more; and/or an abdominal injury requiring emergency laparotomy, laparoscopy or angioembolisation; and/or admission to the intensive care unit for management of an abdominal injury.
  • Presentation within 24 hours of injury.
  • Informed consent provided by the patient or, for incapacitated patients, by a legal representative, with deferred consent procedures as specified in the protocol.

Exclusion criteria

Exclusion Criteria:

  • Death on arrival, or within the first 15 minutes of admission before meaningful resuscitation or data capture.
  • Isolated minor abdominal injury not meeting the severity definition (AIS-abdomen below 3 and not requiring operative or radiological intervention or critical-care admission).
  • Transfer out of the centre before the primary outcome can be ascertained.
  • Known pregnancy (managed on a separate obstetric-trauma pathway).
  • Declined consent.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
430 participants (estimated)
Patient registry
No

Groups and cohorts

  • Severe abdominal trauma

    Consecutive patients aged 16 years or older admitted within 24 hours of injury with blunt or penetrating abdominal trauma meeting at least one severity criterion: AIS-abdomen of 3 or more; an abdominal injury requiring emergency laparotomy, laparoscopy or angioembolisation; or admission to intensive care for management of an abdominal injury. All patients receive standard trauma and post-operative care according to institutional ATLS-based protocols; the study allocates no intervention and does not influence management.

05

What researchers measure

Primary outcomes

  1. In-hospital all-cause mortality

    Death from any cause occurring between hospital admission and hospital discharge, ascertained from the hospital record and reported as the proportion of enrolled patients who die before discharge. Analysed as the dependent variable in the multivariable prediction model.

    Time frame: From admission to hospital discharge or in-hospital death, assessed up to 90 days

Secondary outcomes

  1. Early (24-hour) mortality

    Death from any cause within 24 hours of admission, reported as a proportion of enrolled patients.

    Time frame: First 24 hours after admission

  2. Intensive-care-unit mortality

    Death occurring during the intensive-care admission, reported as a proportion of patients admitted to intensive care.

    Time frame: From ICU admission to ICU discharge or death, assessed up to 90 days

  3. Activation of the massive transfusion protocol

    Proportion of patients in whom the institutional massive transfusion protocol is activated. Massive transfusion is defined as 10 or more units of packed red cells within 24 hours, or 4 or more units within 1 hour.

    Time frame: First 24 hours after admission

  4. Total 24-hour transfusion requirement

    Total number of units of packed red cells transfused within 24 hours of admission, reported as median with interquartile range.

    Time frame: First 24 hours after admission

  5. Damage-control surgery and re-look laparotomy

    Proportion of patients undergoing damage-control surgery, defined as an abbreviated initial laparotomy with planned re-look, and the number of re-look laparotomies per patient.

    Time frame: From admission to hospital discharge, assessed up to 90 days

  6. Major in-hospital complications

    Proportion of patients developing post-injury sepsis, acute kidney injury, acute respiratory distress syndrome, multi-organ dysfunction, surgical-site or intra-abdominal infection, or unplanned reoperation, reported individually and as a composite.

    Time frame: From admission to hospital discharge, assessed up to 90 days

  7. Intensive-care length of stay

    Number of days spent in the intensive care unit during the index admission, reported as median with interquartile range.

    Time frame: From admission to hospital discharge, assessed up to 90 days

  8. Total hospital length of stay

    Number of days from admission to hospital discharge, reported as median with interquartile range.

    Time frame: From admission to hospital discharge, assessed up to 90 days

Other outcomes

  1. Discrimination of the derived multivariable model

    Area under the receiver-operating-characteristic curve (AUROC) with 95% confidence interval for the multivariable logistic regression model predicting in-hospital mortality, reported as apparent and bootstrap optimism-corrected estimates (1,000 replicates).

    Time frame: At completion of enrolment and database lock, up to 12 months after study start

  2. Calibration of the derived multivariable model

    Calibration assessed by the Hosmer-Lemeshow goodness-of-fit test and by calibration slope and intercept from a calibration plot, with bootstrap optimism correction.

    Time frame: At completion of enrolment and database lock, up to 12 months after study start

  3. Comparative discrimination against established trauma scores

    Difference in AUROC between the derived model and the Injury Severity Score, Revised Trauma Score, TRISS and MGAP score, tested by the DeLong method for correlated ROC curves.

    Time frame: At completion of enrolment and database lock, up to 12 months after study start

  4. Performance of a simplified bedside risk score

    Where the multivariable model is robust and well calibrated, a simplified integer score will be derived by assigning points proportional to the regression coefficients; its AUROC, calibration and risk-stratum-specific predicted mortality will be reported with internal bootstrap validation.

    Time frame: At completion of enrolment and database lock, up to 12 months after study start

06

Study locations

1 site
  • Minia University Hospitals /Trauma unit- Department of Surgery, Faculty of Medicine, Minia University
    Minya, Minya Governorate 61519, Egypt
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07843628
Lead sponsor
Minia University
Responsible party
Saleh Khairy Saleh MD (Lecturer, Minia University) — Principal investigator
First posted
Sep 28, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2027 (estimated)
Completion
Oct 30, 2027 (estimated)
Last update
Sep 28, 2026

Study contacts

Saleh K Saleh, MD
Contact
salehkhairy@mu.edu.eg
01201765401 ext. +2
Saleh K Saleh, MD
principal investigator · Minia University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion